These differences are expected and reflect how each body responds hormonally and metabolically to treatment
These appointments can help monitor for side effects, assess the effectiveness of the medication, and make any necessary adjustments to the dosage or treatment plan
This is a frequent inquiry among patients exploring semaglutide weight loss
The biggest difference is that Zepbound is FDA-approved for chronic weight management, while Ozempic is FDA-approved for type 2 diabetes rather than weight loss
For individuals using GLP-1 for weight management, learning about dietary and lifestyle options may complement their medication regimen
Diarrhea and constipation are also commonly observed, each potentially affecting ten to fifteen percent of patients, with individual susceptibility varying based on factors such as baseline gastrointestinal function, dietary habits, and concurrent medications